These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22530942)

  • 41. Cardiomyopathy in Sickle Cell Disease.
    Kaur H; Aurif F; Kittaneh M; Chio JPG; Malik BH
    Cureus; 2020 Aug; 12(8):e9619. PubMed ID: 32923220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fatal Delayed Haemolytic Transfusion Reaction and Hyperhaemolysis Syndrome in a Pregnant Woman with Sickle Cell Anaemia.
    Asnawi AW; Sathar J; Mohamed R; Deraman R; Kumaran S; Hamid SS; Zakaria MZ
    Indian J Hematol Blood Transfus; 2016 Jun; 32(Suppl 1):251-3. PubMed ID: 27408406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The proteomics and interactomics of human erythrocytes.
    Goodman SR; Daescu O; Kakhniashvili DG; Zivanic M
    Exp Biol Med (Maywood); 2013 May; 238(5):509-18. PubMed ID: 23856902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management.
    Farmakis D; Triposkiadis F; Lekakis J; Parissis J
    Eur J Heart Fail; 2017 Apr; 19(4):479-489. PubMed ID: 28000341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated transpulmonary gradient and cardiac magnetic resonance-derived right ventricular remodeling predict poor outcomes in sickle cell disease.
    Nguyen KL; Tian X; Alam S; Mehari A; Leung SW; Seamon C; Allen D; Minniti CP; Sachdev V; Arai AE; Kato GJ
    Haematologica; 2016 Feb; 101(2):e40-3. PubMed ID: 26589907
    [No Abstract]   [Full Text] [Related]  

  • 46. The heart in sickle cell disease.
    Tsironi M; Aessopos A
    Acta Cardiol; 2005 Dec; 60(6):589-98. PubMed ID: 16385919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Erythrocyte ATP, a possible therapeutic approach for sickle cell disease.
    Hoffman JF
    Am J Hematol; 2019 May; 94(5):E117. PubMed ID: 30681180
    [No Abstract]   [Full Text] [Related]  

  • 48. A novel non-invasive method to measure splenic filtration function in humans.
    El Hoss S; Dussiot M; Renaud O; Brousse V; El Nemer W
    Haematologica; 2018 Oct; 103(10):e436-e439. PubMed ID: 29880604
    [No Abstract]   [Full Text] [Related]  

  • 49. Studies on iron metabolism in sickle cell anaemia, sickle cell haemoglobin C disease, and haemoglobin C disease using a large volume liquid scintillation counter.
    Ringelhann B; Konotey-Ahulu F; Dodu SR
    J Clin Pathol; 1970 Mar; 23(2):127-34. PubMed ID: 5423947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular manifestations of sickle cell disease.
    Hammoudi N; Lionnet F; Redheuil A; Montalescot G
    Eur Heart J; 2020 Apr; 41(13):1365-1373. PubMed ID: 31005979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxidative stress and phosphatidylserine exposure in red cells from patients with sickle cell anaemia.
    Hannemann A; Rees DC; Brewin JN; Noe A; Low B; Gibson JS
    Br J Haematol; 2018 Aug; 182(4):567-578. PubMed ID: 29938778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular complications in patients with sickle cell disease.
    Gladwin MT
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):423-430. PubMed ID: 29222288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular complications of sickle cell disease.
    Sachdev V; Rosing DR; Thein SL
    Trends Cardiovasc Med; 2021 Apr; 31(3):187-193. PubMed ID: 32139143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular abnormalities in sickle cell disease.
    Gladwin MT; Sachdev V
    J Am Coll Cardiol; 2012 Mar; 59(13):1123-33. PubMed ID: 22440212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metal accumulation in the renal cortex of a pediatric patient with sickle cell disease: a case report and review of the literature.
    Maximova N; Zanon D; Pascolo L; Zennaro F; Gregori M; Grosso D; Sonzogni A
    J Pediatr Hematol Oncol; 2015 May; 37(4):311-4. PubMed ID: 25811747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maternal death due to sickle cell chronic lung disease.
    Van Enk A; Visschers G; Jansen W; Statius van Eps LW
    Br J Obstet Gynaecol; 1992 Feb; 99(2):162-3. PubMed ID: 1554673
    [No Abstract]   [Full Text] [Related]  

  • 57. Primary prophylaxis in sickle cell disease: is it feasible? Is it effective?
    Thompson AA
    Hematology Am Soc Hematol Educ Program; 2011; 2011():434-9. PubMed ID: 22160070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral manifestations of sickle cell disease.
    Chekroun M; Chérifi H; Fournier B; Gaultier F; Sitbon IY; Ferré FC; Gogly B
    Br Dent J; 2019 Jan; 226(1):27-31. PubMed ID: 30631169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Japanese female with chronic mild anemia and primary iron overloading disease.
    Hattori Y; Kato H; Kato A; Tatsumi Y; Kato K; Hayashi H
    Nagoya J Med Sci; 2020 Aug; 82(3):579-583. PubMed ID: 33132441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute Myocardial Infarction in Sickle Cell Disease: Case Report and Review of the Literature.
    Loutfy M; Tyler B; Sher GD
    Hematology; 1997; 2(6):507-11. PubMed ID: 27415848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.